Head-to-Head

Dermata Therapeutics, Inc. Common Stock vs. Johnson & Johnson

DRMA

Dermata Therapeutics, Inc. Common Stock

$0.57 -4.75%

VS JNJ

Johnson & Johnson

$278.70 -1.36%

Dermata Therapeutics, Inc. Common Stock and Johnson & Johnson are evenly matched on the factors we track — the better pick depends on what you're optimizing for.

Size & Scale

DRMAJNJ
Market Cap $2.95 million $680.19 billion

JNJ leads on 1 of 1 size & scale factors.

Dividend

DRMAJNJ
Dividend Yield — 1.92%

DRMA and JNJ split the dividend factors evenly.

Risk & Sentiment

DRMAJNJ
Short Interest 0.32% 0.67%

DRMA leads on 1 of 1 risk & sentiment factors.

Dig deeper: DRMA overview, DRMA financials, JNJ overview, JNJ financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.